Business Wire

Felpreva ® , Vetoquinol’s New Three-Monthly Feline Parasiticide, Receives Marketing Authorisation from the European Commission

Share

Vetoquinol (Paris: VETO) is delighted to announce that, following positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has granted marketing authorisation for Felpreva® (tigolaner/emodepside/praziquantel) for spot-on prevention and treatment of mixed parasitic infestations/infections in cats.1

Felpreva® is the first spot-on parasiticide for cats that covers tapeworms in addition to other endoparasites including gastrointestinal roundworms and lungworms, and ectoparasites (fleas, ticks and mites) for up to three months with a single dose. It is licensed for treatment of cats with, or at risk from, mixed parasitic infestations/infections, including:

- Endoparasites:
- Gastrointestinal roundworms: infection with Toxocara cati, Toxascaris leonina and Ancylostoma tubaeforme
- Lungworms: infection with Aelurostrongylus abstrusus and Troglostrongylus brevior
- Tapeworms: infection with Dipylidium caninum and Taenia taeniaeformis
- Ectoparasites:
- Flea (Ctenocephalides felis), tick (Ixodes ricinus, Ixodes holocyclus) and mite (Otodectes cynotis) infestations, as well as mild to moderate cases of notoedric mange (caused by Notoedres cati). It can also form part of a treatment strategy for flea allergic dermatitis (FAD).

Matthieu Frechin, Vetoquinol CEO, commented: “Marketing authorisation is a pivotal achievement for both Vetoquinol and Felpreva®. It is a breakthrough treatment with convenience and simplicity of use combined with long-lasting efficacy. We believe that Felpreva® will be a real game changer for this area of veterinary medicine, demonstrating our commitment to the parasiticide market.”

Felpreva® is part of the endectocide class of veterinary parasiticides that covers both internal (endo) and external (ecto) parasites. It is a combination of active substances emodepside and praziquantel, with tigolaner, a novel active ingredient.1

It is estimated that parasiticides make up the largest segment in the companion animal veterinary pharmaceutical market worldwide. Moreover, the fast-growing endectocide category is estimated to make up approximately one quarter of the total companion animal parasiticide market.2

Fifty percent of pet owners in Europe report currently treating their pets with an endectocide product.3 However, research suggests owners are treating cats less frequently than recommended by the European Scientific Counsel Companion Animal Parasites (ESCCAP), which recommends no less than four times per year for deworming in certain risk groups of cats.4.5

Juliana Carrer, International Range Manager at Vetoquinol, said: “With veterinary staff busier than ever, and increasing numbers of new cat owners across Europe, we understand the need to reduce prescribing complexity and increase vets’ confidence in owner compliance. As a qualified veterinarian myself I warmly welcome the approval of Felpreva®.”

It is anticipated that Felpreva® will be made available to veterinarians across Europe in early 2022.

ENDS

References

  1. European Commission Union Register of Veterinary Medicinal Products – Felpreva. 2021. Available from: https://ec.europa.eu/health/documents/community-register/html/v277.htm [Accessed 16 November 2021].
  2. Vetoquinol estimates, based on Market Intelligence Data.
  3. Survey of Pet Owners in EU6 countries and the UK, conducted by Metyis February 2021.
  4. McNamara, J., Drake, J., Wiseman, S. and Wright, I., 2018. Survey of European pet owners quantifying endoparasitic infection risk and implications for deworming recommendations. Parasites & Vectors, 11(1).
  5. ESCCAP Guideline 1: Worm Control in Dogs and Cats. 6th ed. Available at: https://www.esccap.org/uploads/docs/oc1bt50t_0778_ESCCAP_GL1_v15_1p.pdf [Accessed 16 November 2021].

ABOUT VETOQUINOL
Vetoquinol is a leading global animal health company that supplies drugs and non-medicinal products for the livestock (cattle and pigs) and pet (dogs and cats) markets.

As an independent pure player, Vetoquinol designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region.

Since its foundation in 1933, Vetoquinol has pursued a strategy combining innovation with geographical diversification. The Group’s hybrid growth is driven by the reinforcement of its product portfolio coupled with acquisitions in high potential growth markets. Vetoquinol employed 2,540 people as of September 30th, 2021.

Vetoquinol has been listed on Euronext Paris since 2006 (symbol: VETO).

The Vetoquinol share is eligible for the French PEA and PEA-PME personal equity plans.

For further information, go to: www.vetoquinol.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For more information, contact:

MIND+MATTER (Vetoquinol’s PR Partner agency)
Theresa Baker: Email: theresa.baker@ashfieldhealth.com

VETOQUINOL
International Range Manager – Companion Animal Parasiticides
Juliana Carrer: Email: juliana.carrer@vetoquinol.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ITT’s Connector Business Introduces Veam MOVE-MOD™, Delivering True Modularity in Circular Interconnects30.11.2021 17:03:00 CET | Press release

November 30, 2021-- ITT Inc.’s (NYSE: ITT) connector business introduces its ruggedized, modular circular series Veam MOVE-MOD™. The flexible design delivers power, signal, and data in a single connector by utilizing a range of snap-in modules with various contact layouts to match individual system requirements. Developed for use in harsh environments, these ultra-durable connectors are suitable for a wide range of applications, including rail, heavy and off-road vehicles, alternative energy and infrastructure, robotics, and other industrial equipment. “Our customers have relied on Veam connectors to overcome their critical challenges for more than 60 years. MOVE-MOD is a next-generation solution designed to meet their evolving needs,” says Ellen McMillan, Vice President and General Manager Europe, ITT Connect and Control Technologies. “The modular nature of these innovative connectors give long-term flexibility to adapt, convert and expand connectivity post-design-in by simply swappin

Interactive Brokers Expands Tools for Global Investors30.11.2021 16:00:00 CET | Press release

Interactive Brokers Group (Nasdaq: IBKR), a global brokerage firm, today introduced GlobalAnalyst, a new tool that lets investors compare the relative valuations and financial metrics of stocks globally. GlobalAnalyst is designed for investors interested in international portfolio diversification to discover undervalued companies that may have greater growth potential. Recognizing that it can be challenging for investors to evaluate the relative merits of stocks traded in different currencies, Interactive Brokers created a simple yet powerful tool to compare any number of stocks by various metrics in one of 27 currencies of the user’s choice. Similarly, users may buy and sell and follow these stocks in the currency of their choice, all in one account on one screen. Using GlobalAnalyst, investors can search for stocks by region, country, industry, market capitalization and currency to identify undervalued stocks worldwide. A table displays current market and various financial metrics, s

New 7197PCP-DIN-NX Controller Improves Operational Efficiency by Allowing Centralized Control of Volumetric Dispensing Pumps30.11.2021 15:15:00 CET | Press release

Nordson EFD, a Nordson company (NASDAQ: NDSN) and leading precision fluid dispensing systems manufacturer, introduces the 7197PCP-DIN-NX controller for 797PCP progressive cavity pumps. This controller provides Ethernet connection with Transmission Control Protocol / Internet Protocol (TCP/IP) for Smart Factory and Industry 4.0 manufacturing integration. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211130005031/en/ Improve operational efficiency by programming 797PCP volumetric dispensing pumps directly from a PLC via 7197PCP-DIN-NX controllers. (Photo: Business Wire) “This is enabling technology that allows our customers to be more lean, more efficient, more productive and more versatile as we prepare to enter fourth industrial revolution,” said Claude Bergeron, Senior Product Line Manager, Nordson EFD. “By helping manufacturers prepare, we ensure they won’t get left behind as Smart Factories transfer significant value to

AGCO Agriculture Foundation and MANRRS Announce a Three-Year Partnership to Advance Minority Representation in the Agricultural Industry30.11.2021 15:00:00 CET | Press release

The AGCO Agriculture Foundation (AAF), a private foundation committed to ending hunger through sustainable agricultural development, today announced a three-year partnership with Minorities in Agriculture, Natural Resources, and Related Sciences (MANRRS) to increase student representation from underrepresented backgrounds and to promote the agriculture industry as an admirable and sound career choice. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211130005271/en/ AGCO Agriculture Foundation announces partnership with MANRRS (Graphic: Business Wire) Funded by the AAF, the project will provide scholarship opportunities for tailored internship roles and support for hiring talent from underrepresented groups. The focus areas will be agronomy, agribusiness, engineering, data science, software development, sustainability, field technicians, and related disciplines. The goal is to increase diversity and promote the agricultural in

Sekisui House, Ltd.: Working With Customers for 20 Years to Conserve Urban Biodiversity With the Gohon no ki Indigenous Landscaping Concept30.11.2021 15:00:00 CET | Press release

Sekisui House, Ltd. (TOKYO:1928) has been pursuing the conservation of biodiversity since 2001 by creating green networks in urban residential districts under its Gohon no ki (“five trees”) indigenous landscaping concept. Together with the University of the Ryukyus1, the company has analyzed the outcome of the Gohon no ki Project that it has implemented with 1 million customer households2 over the space of 20 years, and has designed the world’s first mechanism for quantitatively evaluating urban biodiversity. It has published this qualitative evaluation mechanism today as a nature-positive methodology for promoting the conservation of biodiversity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211130005350/en/ Results of quantitative evaluation analysis (1) - The number of native tree species in each region—the foundation of regional biodiversity—has increased tenfold. (Graphic: Business Wire) The Gohon no ki Project Since

CHG Healthcare Switches to Rimini Street to Achieve Better System Availability, Smoother Operation and Enhanced Outcomes for 25 Million Patients Annually30.11.2021 15:00:00 CET | Press release

Rimini Street, Inc. (NASDAQ: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced that CHG Healthcare, the nation’s largest privately-held healthcare staffing company, has switched to Rimini Street support for its JD Edwards software. By switching support providers, CHG Healthcare now has an extension of its in-house IT team that includes Rimini Street’s expert, forward-thinking engineers who provide true, follow-the-sun, around the clock global support. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211130005173/en/ CHG Healthcare Switches to Rimini Street to Achieve Better System Availability, Smoother Operation and Enhanced Outcomes for 25 Million Patients Annually (Photo: Business Wire) Assuring Medical Staff is Available to Serve Patients Headquartered in Midvale, Utah, CHG Healthcare

Shiji Selects Planview to Standardize its Project Portfolio Management Practices30.11.2021 15:00:00 CET | Press release

Planview, a global leader in Portfolio Management and Work Management solutions, today announced that Shiji, a leading multi-national technology company that provides software solutions and services for enterprise companies in the hospitality, food service, retail, and entertainment industries, has selected Planview Clarizen™ to standardize its project portfolio management (PPM) practices. This relationship will enable Shiji to engage with customers more effectively, driving customer success faster. Planview Clarizen creates a single point of entry for all projects, with a consistent and transparent view of progress, allowing Shiji’s executives to have the data they need for confidence in effective decision-making throughout the project lifecycle. Through this partnership, Shiji builds on its mission to provide a complete and modern technology stack for its customers, by selecting a modern PPM technology solution to assure that Shiji’s global services organization is scalable, secure,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom